GE HealthCare issues senior notes and $750 million term loan to fund Intelerad deal
On December 15, 2025, GE HealthCare issued $600 million of 4.150% senior notes due 2028 and $650 million of 4.950% senior notes due 2035. On December 12, 2025, it also agreed to a three-year, $750 million unsecured term loan with JPMorgan Chase Bank, N.A. as administrative agent. The company says it will use these proceeds and cash on hand to pay the purchase price for its previously announced acquisition of Intelerad Medical Systems, which adds new debt that shareholders should weigh against the deal.
Key points
- $600 million 4.150% senior notes due December 15, 2028, and $650 million 4.950% senior notes due December 15, 2035, issued December 15, 2025
- $750 million three-year unsecured term loan under a credit agreement dated December 12, 2025, with JPMorgan Chase Bank, N.A. as administrative agent; the loan will be made in a single borrowing on a future date
- Proceeds, the term loan and cash on hand are intended to pay the purchase price for the Intelerad Medical Systems acquisition
- The term loan agreement includes covenants limiting liens, fundamental change transactions, leverage and subsidiary debt, plus a change-of-control event of default
The filing
Written by AI on Nov 8, 2026, 1:30 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on December 15, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.